Insights

Niche Focus Entegrion's emphasis on areas with limited competition and profound medical needs presents a sales path to niche veterinary and translational research customers. Target channels include veterinary clinics, university animal health labs, specialty diagnostic labs, and biotech CROs. Propose joint development agreements or pilot programs to demonstrate the VCM Vet platform and build case studies.

Vet Market Entry The VCM Vet viscoelastic coagulation testing platform is commercially available to North American animal health and science customers, creating a ready-to-sell product for BD teams. Target personas include veterinary surgeons, lab managers, and principal investigators in veterinary schools. Outline outreach strategies: pilot deployments, procurement approvals, and value messaging around faster, point-of-care coagulation insights to improve surgical outcomes.

Data Platform Entegrion's tech stack signals readiness for cloud-based data capture, analytics and integrations with lab information systems. Position the offering as a data-enabled solution that can integrate with existing MySQL backends, EHR/LIMS, and secure cloud platforms. Sales plays include data dashboards, remote monitoring, and cohort analyses to drive efficiency and evidence generation for regulators and academics.

Growth Funding With revenue in the lower tens of millions and a 14 million funding base, Entegrion has growth runway to scale manufacturing, expand sales, and broaden distribution. Opportunities for business development include licensing, co-development, or channel partnerships with veterinary pharma firms and CROs to accelerate market reach and reduce go-to-market costs.

Strategic Partnerships Entegrion's unique position and limited direct competition make partnerships with larger biopharma device players attractive for distribution, integration, or joint development. Target potential partners in the animal health and translational science spaces who can complement the VCM Vet platform with broader diagnostic portfolios or global reach.

Entegrion, Inc. Tech Stack

Entegrion, Inc. uses 8 technology products and services including RSS, GoDaddy Website Builder, MySQL, and more. Explore Entegrion, Inc.'s tech stack below.

  • RSS
    Content Management System
  • GoDaddy Website Builder
    Content Management System
  • MySQL
    Database
  • Google Cloud
    Infrastructure As A Service
  • PWA
    Miscellaneous
  • Cloudflare Bot Management
    Security
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology

Entegrion, Inc.'s Email Address Formats

Entegrion, Inc. uses at least 1 format(s):
Entegrion, Inc. Email FormatsExamplePercentage
FLast@entegrion.comJDoe@entegrion.com
53%
First.Last@entegrion.comJohn.Doe@entegrion.com
36%
Last@entegrion.comDoe@entegrion.com
11%

Frequently Asked Questions

Where is Entegrion, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Entegrion, Inc.'s main headquarters is located at Durham, North Carolina 27709 United States. The company has employees across 1 continents, including North America.

What is Entegrion, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Entegrion, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Entegrion, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Entegrion, Inc.'s official website is entegrion.com and has social profiles on LinkedInCrunchbase.

What is Entegrion, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Entegrion, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Entegrion, Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, Entegrion, Inc. has approximately 12 employees across 1 continents, including North America. Key team members include Ceo - Chairman: J. M.Chief Technology Officer: J. D.Chief Technology Advisor: R. D.. Explore Entegrion, Inc.'s employee directory with LeadIQ.

What industry does Entegrion, Inc. belong to?

Minus sign iconPlus sign icon
Entegrion, Inc. operates in the Biotechnology Research industry.

What technology does Entegrion, Inc. use?

Minus sign iconPlus sign icon
Entegrion, Inc.'s tech stack includes RSSGoDaddy Website BuilderMySQLGoogle CloudPWACloudflare Bot ManagementBootstrapX-Content-Type-Options.

What is Entegrion, Inc.'s email format?

Minus sign iconPlus sign icon
Entegrion, Inc.'s email format typically follows the pattern of FLast@entegrion.com. Find more Entegrion, Inc. email formats with LeadIQ.

How much funding has Entegrion, Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2026, Entegrion, Inc. has raised $14M in funding. The last funding round occurred on Jul 05, 2022 for $14M.

When was Entegrion, Inc. founded?

Minus sign iconPlus sign icon
Entegrion, Inc. was founded in 2002.
Entegrion, Inc. logo

Entegrion, Inc.

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Entegrion, Inc. is a biotechnology research company headquartered in Durham, North Carolina (27709), with a workforce of 11 to 50 employees and a website at https://entegrion.com. The company works to identify opportunities, create new devices and biological technologies, and advance them through development to address specific medical needs. Its pipeline is characterized by pursuing areas with limited competition and substantial unmet needs, with development plans designed to deliver products that are ready for market. In 2018, Entegrion announced that its VCM Vet viscoelastic coagulation testing platform became commercially available to North American animal health and science customers. Financial data indicate revenue in the range of $10 million to $25 million and total funding of about $14 million.

Section iconCompany Overview

Headquarters
Durham, North Carolina 27709 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2002
Employees
11-50

Section iconFunding & Financials

  • $14M

    Entegrion, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Jul 05, 2022 in the amount of $14M.

  • $10M$25M

    Entegrion, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $14M

    Entegrion, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Jul 05, 2022 in the amount of $14M.

  • $10M$25M

    Entegrion, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.